Unlocking Potential: Microfluidics Powers Protein Expression Market Growth

The global protein expression market is expected to experience substantial growth in the coming years, projected to expand from $2.9 billion in 2022 to $5.4 billion by 2027 at a compound annual growth rate (CAGR) of 13.3%. This burgeoning market is driven by several key factors, including the increasing demand for protein biologics, particularly in the treatment of chronic diseases such as cancer, autoimmune disorders, and other serious conditions.

As the life science and biopharmaceutical industries continue to thrive, the focus on recombinant protein expression and the availability of investments for protein-based research are providing further impetus to the market's growth. However, the high cost of protein expression reagents and instruments remains a restraining factor, potentially limiting adoption in certain areas.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

One of the notable trends shaping the market is the emergence of microfluidics, an advanced technique offering robust solutions for protein expression studies and analysis. Microfluidic technologies, such as droplet-based microfluidic (DBM) high-throughput screening and microfluidic antibody capture (MAC) chips, are enabling more efficient and precise evaluation of protein expression levels and protein modifications.

While the market faces challenges related to undesired post-translational modifications and the complexities of protein purification, the mammalian cell expression system segment continues to dominate, driven by its low cost and ease of use.

Geographically, North America currently leads the protein expression market, propelled by the region's strong biotechnology and pharmaceutical industries, the prevalence of chronic disorders, and increased investments in protein-based therapeutics research.

Key players in the global protein expression market include Thermo Fisher Scientific, Merck KGaA, GenScript Biotech Corporation, Agilent Technologies, Danaher Corporation, Sartorius AG, Takara Bio, Bio-Rad Laboratories, Lonza Group AG, Promega Corporation, New England Biolabs, and Oxford Expression Technologies Ltd.

As the demand for protein biologics continues to surge and technological advancements unlock new possibilities, the protein expression market is poised for sustained growth, driving innovation and propelling the development of groundbreaking therapeutics.

Comments

Post a Comment

Popular posts from this blog

From Pain Management to Drug Delivery: The Rising Trajectory of Transdermal Patches

Image
The global transdermal patches market is poised for significant expansion in the coming years, projected to grow from $6.2 billion in 2023 to $8.0 billion by 2029 at a compound annual growth rate (CAGR) of 4.5%. This burgeoning market is driven by several key factors, including the rising prevalence of chronic diseases, the increasing adoption of analgesic patches, technological advancements in transdermal patch development, and a shift away from traditional injections toward more convenient and patient-friendly transdermal delivery systems. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=190809043 One of the primary driving forces behind this growth is the growing popularity of analgesic patches for pain management. These patches offer a localized and controlled release of painkillers through the skin, reducing the risk of systemic adverse effects associated with oral medications. Patients with chronic pain disorders are increasingly turning to anal...
Read more

Introducing the Future of Beauty: Cutting-Edge Medical Aesthetics Treatments

Image
Introduction to Medical Aesthetics: Medical aesthetics is a field of medicine that focuses on improving the appearance of the body through various treatments, such as laser treatments, chemical peels, injectables, and fillers. It is a combination of medical and cosmetic treatments, which are designed to enhance a patient’s natural beauty, while also addressing any health concerns a patient may have. Medical aesthetics has become increasingly popular in recent years, as more people seek to improve their appearance and overall health. The benefits of medical aesthetics treatments are numerous. Patients can achieve a more youthful and vibrant look, improve skin tone and texture, reduce wrinkles and fine lines, correct discoloration and sun damage, and even out skin tone. Additionally, medical aesthetic treatments can help with body contouring and scarring, as well as providing a boost to self-confidence. The results of medical aesthetic treatments can last for many months or even yea...
Read more

Scaffold Products Lead Tissue Engineering Market Growth, Driven by Orthopedic Applications

The global tissue engineering market is projected to expand from $4.4 billion in 2023 to $8.9 billion by 2028, representing a strong CAGR of 15.3%. Key growth drivers include the rising need for advanced regenerative medicines to treat chronic and degenerative diseases, as well as increasing incidence of traumatic injuries from accidents. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34135173 While high treatment costs currently restrain market growth, exciting technological advancements like 3D bioprinting, organ-on-chip technology, and Quantum Magnetic Resonance Therapy (QMRT) present attractive future growth opportunities. Traditional organ transplants remain a more cost-effective alternative currently and are a challenge the industry must overcome. The tissue engineering ecosystem involves hospitals, clinics, technology providers, regulatory bodies, and collaborative networks all working together to advance tissue engineering solutions. Sca...
Read more